Calls for papers
-
Aptuit has named Manuela Leone as Executive VP, Operations and General Manager of the Aptuit Center for Drug Discovery & Development in Verona, Italy, where the company provides inhaled drug development and clinical supply manufacturing… Read more . . .
-
California-based biopharmaceutical company OrPro Therapeutics says that pre-clinical studies of its lead compound, ORP-100, an inhaled thioredoxin, has shown that ORP-100 reduces the viscosity and adhesiveness of the sputum of cystic fibrosis patients both in… Read more . . .
-
The Portuguese Health Authority (Infarmed) has approved Sandoz’s AirFluSal Forspiro salmeterol/fluticasone DPI for the treatment of asthma and COPD, triggering a €1.5 million milestone payment to developer Vectura. Sandoz licensed AirFluSal Forspiro from Vectura in… Read more . . .
-
Boehringer Ingelheim has announced that the Striverdi Respimat olodaterol soft mist inhaler is now available in the United States. The FDA approved Striverdi Respimat for the treatment of COPD in July 2014. The company said… Read more . . .
-
California-based CDMO Formex has announced the hires of two new scientists, Ke Shi and Wade Pathak, as well as the acquisition of new spray drying and capsule filling equipment. Formex Senior Director of Business Development… Read more . . .
-
Teva Pharmaceutical has completed a strategic review of its core therapeutic areas and will focus its development efforts on central nervous system and respiratory drugs, the company has announced. According to the announcement, 14 drug… Read more . . .
-
Savara Pharmaceuticals has announced the completion of enrollment in a Phase 2 trial of its AeroVanc vancomycin DPI for the treatment of for the treatment of methicillin-resistant S. aureus (MRSA) lung infections in cystic fibrosis… Read more . . .
-
Retrophin has announced that Stephen Aselage will take over as interim CEO immediately, replacing company founder and CEO Martin Shkreli. According to reports, Shkreli was fired for “stock trading irregularities” and other rules violations. Aselage… Read more . . .
-
Twenty-five years after its first meeting in a Glaxo Group Research lecture theater, the Aerosol Society’s annual Drug Delivery to the Lungs conference marks its silver anniversary with DDL 25, taking place December 10-12 at… Read more . . .
-
Boehringer Ingelheim has announced that it will spend over €100 million to increase production capacity for the Respimat inhaler at its Dortmund, Germany site to 44 million units per year. In addition, the company said,… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
July 13-July 16: 2026 ISAM Congress, Taipei, Taiwan
September 15-September 18: DDL New Researcher Network Summer Event, London, UK
September 16-September 17: IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA
September 24-September 25: Inhaled & Nasal Biologics | DNA Forum, Cambridge, UK
October 14-October 15: Advancing Bioequivalence Frameworks for Inhalation and Nasal Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods, Rockville, MD, USA